Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1/2
×
Recurrence
×
belantamab mafodotin
×
Clear all
Filters
3
NCT05714839
2026-01-23
DREAMM-20
GlaxoSmithKline
Phase 1/2
Recruiting
153 enrolled
NCT02343042
2025-12-22
STOMP
Karyopharm Therapeutics Inc
Phase 1/2
Recruiting
300 enrolled